Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cancer Chemotherapy and Pharmacology
Published in: Cancer Chemotherapy and Pharmacology 3/2000

01-02-2000 | ORIGINAL ARTICLE

Double high-dose chemotherapy with stem cell rescue (HD-SCR) in patients with breast cancer – effect of sequence

Authors: Emil Frei III, Gulshan Ara, Beverly Teicher, Craig Bunnell, Paul Richardson, Catherine Wheeler, Kenneth Tew, Anthony Elias

Published in: Cancer Chemotherapy and Pharmacology | Issue 3/2000

Login to get access
Metadata
Title
Double high-dose chemotherapy with stem cell rescue (HD-SCR) in patients with breast cancer – effect of sequence
Authors
Emil Frei III
Gulshan Ara
Beverly Teicher
Craig Bunnell
Paul Richardson
Catherine Wheeler
Kenneth Tew
Anthony Elias
Publication date
01-02-2000
Publisher
Springer-Verlag
Published in
Cancer Chemotherapy and Pharmacology / Issue 3/2000
Print ISSN: 0344-5704
Electronic ISSN: 1432-0843
DOI
https://doi.org/10.1007/s002800050035

Other articles of this Issue 3/2000

Cancer Chemotherapy and Pharmacology 3/2000 Go to the issue

ORIGINAL ARTICLE

Pharmacokinetics and metabolism of docetaxel administered as a 1-h intravenous infusion

ORIGINAL ARTICLE

Pharmacokinetics of levamisole in cancer patients treated with 5-fluorouracil

ORIGINAL ARTICLE

Tumor apoptosis induced by epoxide-containing piperazines, a new class of anti-cancer agents

ORIGINAL ARTICLE

Effect of P-glycoprotein modulation with cyclosporin A on cerebrospinal fluid penetration of doxorubicin in non-human primates

ORIGINAL ARTICLE

Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma

ORIGINAL ARTICLE

Modulation of Adriamycin cytotoxicity and transport in drug-sensitive and multidrug-resistant Chinese hamster ovary cells by hyperthermia and cyclosporin A
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits